Human lung cancer-derived mesenchymal stem cells promote tumor growth and immunosuppression
Contact us if these videos are not relevant.
Contact us if these videos are not relevant.
View abstract on PubMed
Summary
This summary is machine-generated.Mesenchymal stem cells from lung cancer enhance tumor growth and protect cancer cells from immune attack by natural killer and T cells, hindering antitumor responses.
Area Of Science
- Oncology
- Immunology
- Stem Cell Biology
Background
- Mesenchymal stem cells (MSCs) are found in solid tumors, influencing the tumor microenvironment.
- Their precise role in cancer progression remains incompletely understood.
Purpose Of The Study
- To investigate the function of MSCs isolated from non-small cell lung cancer (NSCLC) tissues.
- To determine the impact of these MSCs on tumor growth and immune surveillance.
Main Methods
- Isolation and characterization of MSCs from human NSCLC tumor tissues.
- Assessment of MSC morphology, immunophenotype, tumorigenicity, and differentiation potential.
- In vivo studies evaluating the effect of MSCs on tumor growth and immune cell activity (natural killer cells and T cells).
Main Results
- Lung cancer-derived MSCs exhibited typical MSC characteristics and were nontumorigenic with multipotent differentiation capacity.
- Co-culturing tumor cells with these MSCs significantly enhanced tumor growth in vivo.
- MSCs markedly inhibited the cytotoxic activity of natural killer (NK) cells and activated T cells against tumor cells.
Conclusions
- Human lung cancer-derived MSCs promote tumor progression.
- These MSCs shield tumor cells from immune destruction by suppressing the antitumor functions of NK and T cells.
Contact us if these videos are not relevant.
Contact us if these videos are not relevant.
Related Concept Videos
Mesenchymal stem cells (MSCs) are adult stem cells that can differentiate into most connective tissue cell types, except for hematopoietic cells, depending upon the source of MSCs. For example, bone-marrow-derived MSCs (BM-MSCs) can differentiate into osteocytes, hepatocytes, and pancreatic and neuronal cells. MSCs can be isolated from various sources such as bone marrow, placenta, adipose tissue, teeth, and Wharton’s jelly, a gelatinous substance in the umbilical cord. The ease of their...
Early diagnosis and treatment can often cure cancer. However, even with treatment, residual cells called cancer stem cells (CSC) might remain, often causing tumor recurrence. These cancer stem cells possess the potential for self-renewal and multi-lineage differentiation and are often responsible for the therapeutic resistance displayed in most cancers.
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...